Journal of Molecular and Cellular Cardiology
Volume 47, Issue 6 , Pages 752-760 , December 2009

Mechanistic insights into folic acid-dependent vascular protection: Dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: A novel HPLC-based fluorescent assay for DHFR activity

Received 24 March 2009 ,Revised 23 June 2009 ,Accepted 26 July 2009.

References 

  1. Chivu CM, Tulchinsky TH, Soares-Weiser K, Braunstein R, Brezis M. A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy. Am. J. Health Promot. 2008;22:237–245
  2. Taparia S, Gelineau-van Waes J, Rosenquist TH, Finnell RH. Importance of folate-homocysteine homeostasis during early embryonic development. Clin. Chem. Lab. Med. 2007;45:1717–1727
  3. Maron BA, Loscalzo J. The treatment of Hyperhomocysteinemia. Annu. Rev. Med. 2008;
  4. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 1969;56:111–128
  5. McCully KS. Homocysteine, vitamins, and vascular disease prevention. Am. J. Clin. Nutr. 2007;86:1563S–1568S
  6. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 1998;338:1042–1050
  7. Loscalzo J. Key references: homocysteine and atherothrombotic vascular disease. J. Thromb. Thrombolysis. 2000;9:125–126
  8. Yap S, Boers GH, Wilcken B, Wilcken DE, Brenton DP, Lee PJ, et al. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler. Thromb. Vasc. Biol. 2001;21:2080–2085
  9. Wilcken B, Turner B. Homocystinuria. Reduced folate levels during pyridoxine treatment. Arch. Dis. Child. 1973;48:58–62
  10. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J. Clin. Invest. 1976;57:1079–1082
  11. Weiss N, Heydrick S, Zhang YY, Bierl C, Cap A, Loscalzo J. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2002;22:34–41
  12. Weiss N, Heydrick SJ, Postea O, Keller C, Keaney JF, Loscalzo J. Influence of hyperhomocysteinemia on the cellular redox state—impact on homocysteine-induced endothelial dysfunction. Clin. Chem. Lab. Med. 2003;41:1455–1461
  13. Loscalzo J. Homocysteine trials—clear outcomes for complex reasons. N. Engl. J. Med. 2006;354:1629–1632
  14. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298:1163–1170
  15. Ray JG, Kearon C, Yi Q, Sheridan P, Lonn E. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial. Ann. Intern. Med. 2007;146:761–767
  16. Spence JD, Bang H, Chambless LE, Stampfer MJ. Vitamin Intervention For Stroke Prevention trial: an efficacy analysis. Stroke. 2005;36:2404–2409
  17. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 2006;354:1567–1577
  18. Baigent C, Clarke R. B vitamins for the prevention of vascular disease: insufficient evidence to justify treatment. JAMA. 2007;298:1212–1214
  19. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet. 2007;369:1876–1882
  20. Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA. 2006;296:2720–2726
  21. Wald DS, Wald NJ, Morris JK, Law M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ. 2006;333:1114–1117
  22. Moens AL, Vrints CJ, Claeys MJ, Timmermans JP, Champion HC, Kass DA. Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. Am. J. Physiol., Heart Circ. Physiol. 2008;294:H1971–H1977
  23. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 2005;102:9056–9061
  24. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 2000;87:840–844
  25. Oak JH, Cai H. Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes. 2007;56:118–126
  26. Seujange Y, Eiam-Ong S, Tirawatnapong T. Role of angiotensin II on dihydrofolate reductase, GTP-cyclohydrolase 1 and nitric oxide synthase expressions in renal ischemia–reperfusion. Am. J. Nephrol. 2008;28:692–700
  27. Ren J, Li H, Prior BM, Yang HT. Angiotensin converting enzyme inhibition enhances collateral artery remodeling in rats with femoral artery occlusion. Am. J. Med. Sci. 2008;335:177–187
  28. Gao L, Pung YF, Zhang J, Chen P, Wang T, Li M, et al. Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability. Am. J. Physiol., Heart Circ. Physiol. 2009;297:H331–H339
  29. Bauer M, Suppmann S, Meyer M, Hesslinger C, Gasser T, Widmer HR, et al. Glial cell line-derived neurotrophic factor up-regulates GTP-cyclohydrolase I activity and tetrahydrobiopterin levels in primary dopaminergic neurones. J. Neurochem. 2002;82:1300–1310
  30. Lu W, Li H, Zhang Y, Ang CY. Rapid method for the determination of total 5-methyltetrahydrofolate in blood by liquid chromatography with fluorescence detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002;766:331–337
  31. Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, Lee J, et al. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation. 2006;114:1193–1201
  32. Kalmbach RD, Choumenkovitch SF, Troen AP, Jacques PF, D'Agostino R, Selhub J. A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate. J. Nutr. 2008;138:2323–2327
  33. Aiso K, Nozaki T, Shimoda M, Kokue E. Assay of dihydrofolate reductase activity by monitoring tetrahydrofolate using high-performance liquid chromatography with electrochemical detection. Anal. Biochem. 1999;272:143–148
  34. Kaufman BT, Kemerer VF. Purification and characterization of beef liver dihydrofolate reductase. Arch. Biochem. Biophys. 1976;172:289–300
  35. Webber S, Whiteley JM. Comparative activity of rat liver dihydrofolate reductase with 7,8-dihydrofolate and other 7,8-dihydropteridines. Arch. Biochem. Biophys. 1985;236:681–690
  36. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 2003;24:471–478
  37. Doshi SN, McDowell IF, Moat SJ, Lang D, Newcombe RG, Kredan MB, et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?. Arterioscler. Thromb. Vasc. Biol. 2001;21:1196–1202
  38. Shirodaria C, Antoniades C, Lee J, Jackson CE, Robson MD, Francis JM, et al. Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation. 2007;115:2262–2270
  39. Chambers JC, Ueland PM, Obeid OA, Wrigley J, Refsum H, Kooner JS. Improved vascular endothelial function after oral B vitamins: an effect mediated through reduced concentrations of free plasma homocysteine. Circulation. 2000;102:2479–2483
  40. Bellamy MF, McDowell IF, Lewis MJ. Folic acid in endothelial function in familial hypercholesterolemia. Circulation. 2000;102:E92

PII: S0022-2828(09)00317-4

doi: 10.1016/j.yjmcc.2009.07.025

Journal of Molecular and Cellular Cardiology
Volume 47, Issue 6 , Pages 752-760 , December 2009

Article Tools

* Image Usage & Resolution